Novo Nordisk said it expects weaker sales growth of its popular weight-loss drug Wegovy due to competition from copycat drugs ...

As the Trump administration begins to make its mark on the Medicare drug price negotiation program, litigation over the ...

Shares of Novo Nordisk skidded on Tuesday as the Danish drugmaker reduced its expectations on wildly popular drugs Ozempic ...

U.S.-listed shares of Novo Nordisk sank in premarket trading Tuesday after the Danish drugmaker cut its full-year outlook and ...

The pharmaceutical giant cut its guidance and said U.S. sales of Ozempic grew more slowly.

Under the Inflation Reduction Act, medications with the same active ingredient will be treated as the same drug for price ...

UnitedHealth (UNH) warned rising medical costs will weigh on 2025 earnings with a record-high medical loss ratio, driven by Medicare and outpatient care. Yahoo Finance Senior Reporter Anjalee Khemlani ...

Novo Nordisk NVO shares have plunged 19.9% year to date, following a string of unfavorable outcomes, both pipeline and regulatory, that have led investors to bet against the company. The company ...

With promising new obesity treatments in the pipeline, 24/7 Wall St. projects huge upside for Novo Nordisk stock through 2030 ...

UnitedHealth shares continue to struggle after the company issued a fresh outlook for 2025, indicating revenue and adjusted ...